Mycobacterium tuberculosis KasA as a drug target: Structure-based inhibitor design. - Rudraraju RS; Daher SS; Gallardo-Macias R; Wang X; Neiditch MB; Freundlich JS (Frontiers in cellular and infection microbiology, 2022)